Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04181944 · ClinicalTrials.gov registry record · NA
Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA)
A NA study, sponsored by Memorial Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT04181944: Completed NA study, sponsored by Memorial Healthcare System.
NCT04181944 is a NA study that has completed, run by Memorial Healthcare System. The registered enrollment target is 115 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04181944, a NA study, has completed, sponsored by Memorial Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the potential interventions of exercises in adults with sickle cell anemia (SCA) and cardiopulmonary disease; only including the more severe genotypes of sickle cell disease.
Primary Outcome
100 participants with sickle cell disease exercise preference based on the survey results, decrease the severity of cardiovascular disease in patients with sickle cell disease
Interventions
- OTHER Exercise Treatment Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2020-06-14 |
| Est. Completion | 2022-10-01 |
| Phase | NA |
What the finished NCT04181944 record still lists
NCT04181944 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Exercise Treatment Group is the first listed.
NCT04181944 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04181944 about?
NCT04181944 is a clinical study titled "Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA)". The purpose of this study is to assess the potential interventions of exercises in adults with sickle cell anemia (SCA) and cardiopulmonary disease; only including the more severe genotypes of sickle cell disease.
What is the current status of trial NCT04181944?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2020-06-14. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT04181944?
The interventions under investigation include: Exercise Treatment Group (OTHER).
Who is sponsoring clinical trial NCT04181944?
This trial is sponsored by Memorial Healthcare System, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04181944's enrollment target sits among peer trials
115 810th of 2000 higher than 1,190 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI